JAK2 Gene Editing


Our promise to you:
Guaranteed product quality, expert customer support.


JAK2 Gene Editing    

JAK2 is a member of the Janus kinase (JAKs), which includes JAK1-3 and TYK2. The JAK2 gene is located on the chromosome at 9p24.1. JAKs are non-receptor protein tyrosine kinases that play important roles in regulating hematopoiesis, immune system, and cellular metabolism. Binding of cytokines to the extracellular region of their cognate receptor induces receptor dimerization and promotes trans-phosphorylation (activation) of the associated JAK. Activated JAK phosphorylates specific tyrosine residues on cytokine receptors, followed by phosphorylation of signal transduction and activator of transcriptional (STAT) proteins through their SH2 (Src homology 2) domain to recruit phosphorylated receptors. The phosphorylated STAT then translocates to the nucleus to initiate a specific transcriptional program. The JAK-STAT signal transduction pathway is critical for biological development and homeostasis, especially in immunity.

JAK2 has been shown to be the predominant JAK activated in the response multiple cytokines, including Epo, IL-3, and granulocyte/macrophage colony-stimulating factor (GM-CSF), IL-5, thrombopoietin (TPO), growth hormone and prolactin. JAK2 protein is particularly important for controlling hematopoiesis in hematopoietic stem cells. These stem cells are located in the bone marrow and may develop into red blood cells, white blood cells, and platelets. Its mutations are closely related to a variety of diseases, including polycythemia vera (PV), essential thrombocythemia and myelofibrosis, and other myeloproliferative disorders. Among them, the presence of JAK2 mutation is one of the methods of clinically confirmed PV. The highly prevalent JAK2 V617F mutation was found in myeloproliferative neoplasms (MPN), and JAK2 gene fusion with TEL (ETV6) (TEL-JAK2) and PCM1 genes are also found in patients with leukemia. Therefore, JAK2 has become a major target of inhibition. Further in-depth study of JAK2 pathogenic activation will enable the development of novel small molecule targeted therapeutics.

JAK2 Gene Editing Service

CRISPR/Cas9 PlatformCB is one of the leading gene editing biotechnology companies and committed to building efficient systems and procedures to meet the needs and timelines of clients working in the CRISPR/Cas9 gene editing. With deep gene editing knowledge and extensive experience in experimental operation and data processing, we will help you better control targeted gene editing in cell lines or animal models within shorter turnaround time and lower price. Our CRISPR/Cas9 gene editing services contains DNA deletion, conditional knockout/knockin, point mutation and report gene insertion, etc.

  • JAK2 Gene Editing Cell Line Generation

CRISPR/Cas9 PlatformCB is very familiar with the culture conditions and genetic backgrounds of >200 distinct cell lines, and have successfully implemented JAK2 CRISPR/Cas9 gene edit in both easy-to-transfect cell lines and hard-to-transfect cells. According to your project needs, we offer you professional custom JAK2 gene editing cell line services from strategy design to final stable cells. Our JAK2 gene editing cell line generation services include:

✧ SgRNA design and synthesis
✧ Transfect the cell line you interest
✧ Select the high expression cell and sort monoclonal cell
✧ Validate the knockout/knockin/point mutation of JAK2 by PCR and sequencing
✧ Produce cryogenic preserved vials of stable cells and a final report

Typically, we develop CRISPR-mediated gene editing cell lines including HEK239T, Hela, HepG2, U87, but we can use other cell lines according to your requirements.

Host cell line: Ba/F3, CHO, MDA-MB-453, MDA-MB-231NIH3T3, T47D, Neuro2a, MCF7, RKO, K562, RAW264.7, etc.

  • JAK2 Gene Editing Animal Model Generation

CRISPR/Cas9 PlatformCB also has extensive experience in incorporating CRISPR-Cas9 technology into animal models, which have been fully recognized by our clients. Based on our platform, we provide a one-stop-shop JAK2 CRISPR/Cas9 gene editing animal service and guarantee at least 2 founders or 3 F1 animals with shorter turnaround time and lower price. Our JAK2 gene editing animal model generation services include:

➢ JAK2 gene conventional knockout animals
➢ JAK2 gene conditional knockout animals
➢ JAK2 point mutation animals
➢ JAK2 knockin animals

Alternative species: mouse, rat, rabbit, zebrafish, C. elegans, etc.

CRISPR/Cas9 PlatformCB is devoted to providing the best gene editing services to accelerate the achievement of your research goals. Our one-stop services range from strategy design to final stable cell lines or F1 animals. In addition, customized service has been provided to meet your special requirements. We guarantee our clients the most reliable and efficient research services to best match your research goals and protect your science investment. If you have any projects need CRISPR/Cas9 gene editing services, don't hesitate to contact us.

Related Products at CRISPR/Cas9 PlatformCB


  1. Stevan R. Hubbard. et al. Mechanistic Insights into Regulation of JAK2 Tyrosine Kinase. Front. Endocrinol. 2018 January; 8: 361.
  2. Scott LM. The JAK2 exon 12 mutations: a comprehensive review. American Journal of Hematology. 2011; 86 (8): 668–76.
  3. E Leroy & S N Constantinescu. Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile janus kinase inhibition. Nature Communication. 2017; 31; 1023–1038.
  4. Evan Parganas. et al.Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors. Cell. 1998; 93 (3): 385-395. 
For research use only. Not intended for any clinical use.


Verification code